Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis Post author:Sam Post published:February 12, 2018 Post category:BioPharma That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace You Might Also Like 26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode September 25, 2017 Asterias Biotherapeutics Extends The Expiration Date Of Certain Warrants And Provides Update On Cash Position February 2, 2017 LEO Pharma Appoints To Lead US Business June 22, 2017
26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode September 25, 2017
Asterias Biotherapeutics Extends The Expiration Date Of Certain Warrants And Provides Update On Cash Position February 2, 2017